37 related articles for article (PubMed ID: 6316192)
1. Neither serotonin disorder is at the core of depression nor dopamine at the core of schizophrenia; still these are biologically based mental disorders.
Fountoulakis KN; Tsapakis EM
Mol Psychiatry; 2024 Jan; 29(1):198-199. PubMed ID: 38374355
[No Abstract] [Full Text] [Related]
2. Methodological concerns in umbrella review of serotonin and depression.
Smith AL; Carvalho AF; Solmi M
Mol Psychiatry; 2024 Jan; 29(1):203-204. PubMed ID: 38374357
[No Abstract] [Full Text] [Related]
3. Platelets: A possible glance into brain biological processes in schizophrenia.
Asor E; Ben-Shachar D
World J Psychiatry; 2012 Dec; 2(6):124-33. PubMed ID: 24175178
[TBL] [Abstract][Full Text] [Related]
4. An intercalation mechanism as a mode of action exerted by psychotropic drugs: results of altered phospholipid substrate availabilities in membranes?
Oruch R; Lund A; Pryme IF; Holmsen H
J Chem Biol; 2010 Jan; 3(2):67-88. PubMed ID: 21270935
[TBL] [Abstract][Full Text] [Related]
5. Impaired platelet [3H]paroxetine binding in female patients with borderline personality disorder.
Ng Ying Kin NM; Paris J; Schwartz G; Zweig-Frank H; Steiger H; Nair NP
Psychopharmacology (Berl); 2005 Nov; 182(3):447-51. PubMed ID: 16052363
[TBL] [Abstract][Full Text] [Related]
6. The role of serotonin in schizophrenia: an overview of the nomenclature, distribution and alterations of serotonin receptors in the central nervous system.
Ohuoha DC; Hyde TM; Kleinman JE
Psychopharmacology (Berl); 1993; 112(1 Suppl):S5-15. PubMed ID: 7831440
[TBL] [Abstract][Full Text] [Related]
7. Platelet [3H]imipramine binding in autism and schizophrenia.
Weizman A; Gonen N; Tyano S; Szekely GA; Rehavi M
Psychopharmacology (Berl); 1987; 91(1):101-3. PubMed ID: 3103151
[TBL] [Abstract][Full Text] [Related]
8. Platelet research in psychiatry.
Wirz-Justice A
Experientia; 1988 Feb; 44(2):145-52. PubMed ID: 2831076
[TBL] [Abstract][Full Text] [Related]
9. Imipramine binding in depression and other psychiatric conditions.
Mellerup ET; Plenge P
Acta Psychiatr Scand Suppl; 1988; 345():61-8. PubMed ID: 2852451
[TBL] [Abstract][Full Text] [Related]
10. Imipramine binding in depressive patients diagnosed according to different criteria.
Plenge P; Mellerup ET; Gjerris A
Acta Psychiatr Scand; 1988 Aug; 78(2):156-61. PubMed ID: 2851919
[TBL] [Abstract][Full Text] [Related]
11. Lack of association between [3H]imipramine binding sites and uptake of serotonin in control, depressed and schizophrenic patients.
Wood PL; Suranyi-Cadotte BE; Nair NP; LaFaille F; Schwartz G
Neuropharmacology; 1983 Oct; 22(10):1211-4. PubMed ID: 6316192
[TBL] [Abstract][Full Text] [Related]
12. Seasonal variation of platelet serotonin uptake and 3H-imipramine binding in normal and depressed subjects.
Egrise D; Rubinstein M; Schoutens A; Cantraine F; Mendlewicz J
Biol Psychiatry; 1986 Mar; 21(3):283-92. PubMed ID: 3004612
[TBL] [Abstract][Full Text] [Related]
13. Circannual variations in the density of tritiated imipramine binding sites on blood platelets in man.
Egrise D; Desmedt D; Schoutens A; Mendlewicz J
Neuropsychobiology; 1983; 10(2-3):101-2. PubMed ID: 6325993
[TBL] [Abstract][Full Text] [Related]
14. Reduced Vmax of 3H-serotonin uptake but unchanged 3H-imipramine binding in the platelets of untreated hypertensive subjects.
Kamal LA; Raisman R; Meyer P; Langer SZ
Life Sci; 1984 May; 34(21):2083-8. PubMed ID: 6328154
[TBL] [Abstract][Full Text] [Related]
15. Platelet [3H]imipramine binding in psychiatric disorders.
Kanof PD; Coccaro EF; Johns CA; Siever LJ; Davis KL
Biol Psychiatry; 1987 Mar; 22(3):278-86. PubMed ID: 3028513
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
